TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZTS

Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

73.00$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZTS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
13.1% 13.9% 14.6% 25.4% 30.7% 28.7% 31.9% 28.5% 23.7% 27.5% 31.9% 30.7%
4.3% 4.2% 4.9% 4.6% 5.3% 6.6% 6.6% 5.8% 5.8% 5.7% 5.4% 5.1%
0.7% 0.9% 0.8% 0.8% 0.9% 1.1% 0.9% 0.7% 0.8% 0.7% 0.8% 0.9%
-0.2% 6.8% 1.8% 5.0% -1.0% 0.5% 2.1% 0.9% -1.0%
-3.3% -4.4% -9.0% -0.5% 1.9% -2.4% -1.3% -4.4% -8.7% -6.0% 0.9% -4.3%
4.1% 4.7% 4.4% 4.2% 5.8% 7.3% 6.8% 6.1% 7.3% 8.6% 7.1% 6.6%
-3.9% -23.4% -4.4% -5.1% -38.8% -8.1% -8.6% -5.9% -10.9% -9.1% -3.4% -7.9%
3.1% 3.5% 3.8% 3.9% 4.2% 5.0% 5.7% 6.1% 7.6% 8.1% 8.5% 9.4%
0.0% -4.3% -6.1% -9.4% -12.0% -10.0% -3.7% -9.6% -19.7% -12.8% -20.1% -34.2%
-0.2% 23.4% -8.3% 9.1% 25.6% -0.1% 11.0% -7.8% 16.6% -15.8% 0.0% 26.4%
-3.2% 15.8% -18.5% -4.7% 9.2% -15.2% 1.8% -23.9% -11.2% -36.4% -28.7% -19.8%
5.7% 5.7% -8.7% 15.8% 0.7% 5.3% 25.0% -1.5% 1.2% -18.0% -0.6% 3.4%
9.0% 9.2% 10.2% 21.1% 24.9% 21.3% 25.1% 22.3% 16.4% 19.0% 24.8% 24.1%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?